Wells Fargo & Company »

Zentalis Pharmaceuticals shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $280k 18k 15.15
2023-09-30 $1.0M 50k 20.06
2023-06-30 $1.8M 65k 28.21
2022-12-31 $63k 3.1k 20.14
2022-09-30 $121k 5.7k 21.25
2022-06-30 $1.3M 47k 28.02
2022-03-31 $5.9M 128k 46.14
2021-12-31 $11M 130k 82.89
2021-09-30 $32M 496k 64.22
2021-06-30 $27M 507k 54.05
2021-03-31 $167k 3.9k 43.18
2020-12-31 $876k 17k 51.93
2020-09-30 $276k 8.5k 32.66
2020-06-30 $252k 5.2k 48.05